in Brussels brought together health care providers, pharmaceutical industry representatives, bankers and insurers, policy makers, as well as clinicians, researchers and patients and patient advocacy groups to discuss the specific needs of cancer survivors. This summit stressed the urgent need to address treatment related morbidity and mortality due to late effects, generally viewed as the domain of medical professionals, as well as the wide variety of societally significant issues related to survivorship such as jobs, life insurance, mortgages, and normal re-integration into society with or after cancer.
